policymed.com19h
Sanofi Sues HHS Over 340B Changes
Sanofi-Aventis US LLC filed a lawsuit against the Department of Health and Human Services (HHS) and the Health Resources and ...
L’Oreal to Sell $3.1 Billion Stake in Sanofi Back to Pharma Group
The deal will diversify the French beauty giant’s funding sources at a time when the industry is undergoing a slowdown.
Daily1d
Sanofi acquires 2.3% of its shares from long-standing shareholder L'Oréal
Paris: Sanofi has announced the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is ...
policymed.com1d
340B Compliance Battle: Sanofi Takes on HRSA and HHS
Recently, Sanofi-Aventis US LLC filed a lawsuit against the Department of Health and Human Services (HHS) and the Health Resources… ...
Sanofi stock price target raised to €120 by Leerink Partners
Sanofi (SAN:FP) (NASDAQ: NASDAQ:SNY) saw its price target increased by Leerink Partners from €113.00 to €120.00, while the firm maintained an Outperform rating on the company's shares. Currently ...
Press Release: Sanofi announces buy back of shares from L’Oréal
Sanofi announces buy back of shares from L’Oréal Paris, February 3, 2025. Sanofi today announces the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is part ...
Cosmetics Business2d
L’Oréal sells €3 billion of Sanofi stock back to pharmaceutical group
The beauty giant said the transaction – selling approximately 29.6 million of its Sanofi shares for €101.5 per share – will ...
FiercePharma6d
Sanofi's RSV antibody Beyfortus, after smashing blockbuster sales threshold, still has room to grow in US: execs
While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...
Pharmabiz1d
Sanofi announces buy back of shares from L’Oréal
Sanofi, an innovative global healthcare company, announces the acquisition of 2.3 per cent of its shares from long-standing shareholder L’Oréal. This transaction is part of Sanofi’s share buyback ...